443 related articles for article (PubMed ID: 21950959)
1. Current perspectives of insulin resistance and polycystic ovary syndrome.
Pauli JM; Raja-Khan N; Wu X; Legro RS
Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
[TBL] [Abstract][Full Text] [Related]
2. Metformin in polycystic ovary syndrome.
Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
Bhathena RK
J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
5. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Sharma ST; Nestler JE
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
[TBL] [Abstract][Full Text] [Related]
7. [Insulin sensitizers in the treatment of polycystic ovary].
Ortiz Núñez DA; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
[TBL] [Abstract][Full Text] [Related]
8. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and polycystic ovary syndrome.
Galluzzo A; Amato MC; Giordano C
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
11. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
12. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
Barbieri RL
Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.
Sirmans SM; Weidman-Evans E; Everton V; Thompson D
Ann Pharmacother; 2012 Mar; 46(3):403-18. PubMed ID: 22388330
[TBL] [Abstract][Full Text] [Related]
14. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Cheang KI; Sharma ST; Nestler JE
Gynecol Endocrinol; 2006 Nov; 22(11):595-604. PubMed ID: 17145645
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
16. Metformin and polycystic ovary syndrome.
Lebinger TG
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
[TBL] [Abstract][Full Text] [Related]
17. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
[TBL] [Abstract][Full Text] [Related]
18. The management of insulin resistance in polycystic ovary syndrome.
Teede HJ; Hutchison SK; Zoungas S
Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
[TBL] [Abstract][Full Text] [Related]
19. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
Seale FG; Robinson RD; Neal GS
J Reprod Med; 2000 Jun; 45(6):507-10. PubMed ID: 10900588
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
